View in EDS

Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential.

Saved in:
Bibliographic Details
Title: Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential.
Authors: Colwill M; Department of Gastroenterology, St George's University Hospital NHS Foundation Trust, London, United Kingdom.; Institute for Infection and Immunity, City St George's University Medical School, London, United Kingdom., Povlsen S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Pollok R; Institute for Infection and Immunity, City St George's University Medical School, London, United Kingdom., Patel K; Department of Gastroenterology, St George's University Hospital NHS Foundation Trust, London, United Kingdom., Goodhand J; Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, United Kingdom., Ahmad T; Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, United Kingdom., Honap S; Department of Gastroenterology, St George's University Hospital NHS Foundation Trust, London, United Kingdom.; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Source: Journal of Crohn's & colitis [J Crohns Colitis] 2025 Sep 28; Vol. 19 (9).
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1876-4479
DOI:10.1093/ecco-jcc/jjaf167